Dear Editor,
I received a postcard this weekend from Senator Daines and President Trump accusing the Biden administration of breaking Medicare with price controls.
The only conclusion that can be drawn from the carefully constructed lies it contained is that the pharmaceutical industry's lobbyists have increased pressure on them to roll back Medicare's ability to negotiate prices on behalf of its members.
The lies that Medicare's ability to negotiate on the behalf of its members will prevent the development of new drugs, reduce access to affordable new medicine and create a 70% cut in research...
Reader Comments(0)